Vagelos P Roy - Dec 9, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**P. Roy Vagelos
Stock symbol
REGN
Transactions as of
Dec 9, 2022
Transactions value $
-$42,937
Form type
4
Date filed
12/13/2022, 03:12 PM
Previous filing
Apr 1, 2022
Next filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -23.1K -6.68% $0.00 322K May 24, 2022 Direct F1
transaction REGN Common Stock Tax liability -$42.9K -57 -0.02% $753.28 322K Dec 9, 2022 Direct
transaction REGN Common Stock Gift $0 -302 -0.24% $0.00 127K Apr 6, 2022 by CLAT
transaction REGN Common Stock Gift $0 -357 -0.28% $0.00 126K Jul 5, 2022 by CLAT
transaction REGN Common Stock Gift $0 -304 -0.24% $0.00 126K Oct 3, 2022 by CLAT
holding REGN Common Stock 2.1K Dec 9, 2022 By 401(k) Plan
holding REGN Common Stock 23.5K Dec 9, 2022 by Spouse as Trustee
holding REGN Common Stock 3.61K Dec 9, 2022 by trust for grandch F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.